Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF effect on MRD in AML
NCT03665480Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Sep 2018
- Primary completion
- Aug 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of filgrastim in neutropenia, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT03665480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03665480.